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ABSTRACT
Zebrafish has become a favorite model organism not
only in genetics and developmental biology, but
also for the study of cancer, neuroscience and meta-
bolism. However, strategies for reverse genetics in
zebrafish are mostly limited to the use of antisense
oligonucleotides, and therefore the development of
other targeting methods is highly desirable. Here,
we report an approach to gene targeting in this sys-
tem in which single-stranded oligonucleotides and
zebrafish Rad52 protein are employed. It has been
proposed that a single-stranded oligonucleotide
containing a mutation can be incorporated into the
genome by annealing to the single-stranded region
of the lagging strand of the replication fork. Rad52
is expected to accelerate the annealing step. In vitro
experiments using purified truncated Rad52 proteins
and replication protein A (RPA) showed that ann-
ealing of oligonucleotides is accelerated by Rad52
in the presence of RPA. We developed a simple and
sensitive PCR-based method to detect point muta-
tions in the genome. In exploratory experiments, we
found that microinjection of single-stranded oligo-
nucleotide targeted to a specific gene together with
truncated Rad52 into zebrafish embryos resulted in a
lowlevelofrecombinantcopiesin3ofthe80embryos
tested under these conditions.
INTRODUCTION
The concept that single-stranded oligonucleotides can be
used to introduce mutations into genomes was ﬁrst explored
by Sherman’s laboratory (1–3). A different study showed
that M13 single-stranded DNA can also be a substrate for
homologous recombination (4). Within the past decade, the
potential of both unmodiﬁed and modiﬁed oligonucleotides
for gene targeting has been extensively studied with the goal
of using this approach for directed mutagenesis and gene ther-
apy of genetic diseases (5–7). Despite their apparent similari-
ties, the methods described seem to involve at least two
different recombination pathways. Recombination mediated
by unmodiﬁed single-stranded oligonucleotides 40–70 resi-
dues in length exhibited strand speciﬁcity determined by
the direction of replication through the site, in that the efﬁci-
ency of single-stranded oligonucleotides that correspond to
Okazaki fragments was 2- to 50-fold higher than those repre-
senting the complementary strand (8,9). High recombination
efﬁciencies (up to 6%) were achieved by overexpressing the
b protein of bacteriophage l, a single-strand DNA-annealing
protein, while introducing targeting single-stranded oligo-
nucleotides into bacteria (8). On the other hand, studies of
modiﬁed oligonucleotides (both chimeric RNA/DNA oligo-
nucleotides and single-stranded oligonucleotides with phos-
phorothioate or 20-O-methyl RNA modiﬁcations at the ends)
have shown that recombination efﬁciency correlates with
the level of transcription, and is at least 5- to 50-fold higher
when the oligonucleotides anneal to the non-template strand
(10–12). The efﬁciency could be also enhanced by genetic
re-engineering of RAD51 in yeast (13). One study has been
published so far that reports recombination of single-stranded
corrective DNA of 236 nt with a vector containing a mutated
EGFP gene after coinjection with RecA protein into zebraﬁsh
embryos (14).
Zebraﬁsh has manyadvantages as a vertebrate model organ-
ism. Its transparent body makes it easier to observe the mor-
phology of organs and cells, and of reporter gene expression.
Forward genetic screens using chemical mutagens have been
successful in discovering many developmental mutations (15),
but strategies for reverse genetics have mostly been limited to
the use of antisense oligonucleotides that are effective for a
limited period of time only (16,17). Recently, methods have
been developed for effectively selecting random mutations in
a gene of interest by resequencing or enzyme digestion assays
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doi:10.1093/nar/gni122(TILLING) after chemical mutagenesis (18,19). As ES cell-
based gene targeting technology is not likely to be available
in zebraﬁsh for some years (20–23), other methods that allow
introduction of targeted modiﬁcations into a gene of interest
are highly desirable.
Early zebraﬁsh embryos undergo cell division every 15 min,
and hence DNA replication proceeds rapidly (24). Further,
microinjection of DNA, mRNA or proteins can easily intro-
duce desired reagents into the embryo. These properties of
zebraﬁsh make it attractive to pursue the potential of unmodi-
ﬁed single-stranded oligonucleotides as site-speciﬁc mutagens
in this organism. Here, we report the characterization of com-
ponents of the recombination machinery in zebraﬁsh that are
involved in targeted mutagenesis, and we provide preliminary
evidence for the ability of an unmodiﬁed single-stranded
oligonucleotide to introduce a site-speciﬁc base substitution
into the zebraﬁsh genome.
MATERIALS AND METHODS
Zebrafish Rad52 expression constructs
The nuclear localization signal from the zebraﬁsh Rad52
C-terminus was generated by annealing of two complementary
synthetic oligonucleotides, BamHI–Rad52NLS–BclI: 50-gatc-
cAGACACGGCCAGATGATGAAGAAACGAAGATTGG-
ACACGT-30 and BclI–SLN25daR–BamHI: 50-gaTCACGTG-
TCCAATCTTCGTTTCTTCATCATCTGGCCGTGTCTg-30.
This annealed fragment was subcloned into the BamHI site of
thepET-15bvector(Novagen)togive‘NLSpET15b’;15amino
acids (GSRHGQMMKKRRLDT) will be added to a protein-
coding sequence that is inserted into the BamHI site of this
construct. Rad52 1–204Q fragment was PCR ampliﬁed with
primer pairs, XhoNde–Rad52F1: 50-CCGctcgagCATatggatta-
tagcagcgggaggcaag-30 and BamHI–Rad52R612: 50-CGggatc-
cTTGGGCCAGGCTGTCAAAC-30. Rad52 1–317Q fragment
was ampliﬁed with XhoNde–Rad52F1 and BamHI–
Rad52R949 (50-CGggatccctGCTGGTCTTTCTTCTCTTGC-
AG-30). These PCR fragments were cut by NdeI and BamHI,
and inserted into the NdeI and BamHI sites of the NLSpET15b
to generate ‘Rad52 1–204Q NLS pET15b’ and ‘Rad52
1–317Q NLS pET15b’.
Expression and purification of zebrafish truncated
Rad52 proteins
Expression constructs in BL21-CodonPlus (DE3)-RIL cells
(Stratagene) were cultured in Luria–Bertani medium supple-
mented with ampicillin and chloramphenicol at 22 Ct oA600
of 0.6, and induced with 1 mM Isopropyl-b-D-thiogalactopy-
ranoside (IPTG) for 3 h. The bacterial pellet was resuspended
in 40 ml of BD TALON xTractor buffer (Clontech) (pH was
adjusted to 8.0 and supplemented with additional 200 mM
NaCl, 5 mM imidazole and Complete protease inhibitor,
EDTA-free, from Roche), treated with 8 mg of lysozyme
and 1 kU of benzonase nuclease (Novagen) for 10 min. The
lysate was centrifuged at 10000 g for 30 min. The supernatant
was ﬁltered through a 0.45 mm pore ﬁlter and incubated with
4 ml bed volume of TALON beads (Clontech) for 1 h. The
beads were pelleted by centrifugation (700 g for 10 min),
resuspended in 20 ml of wash buffer (20 mM Tris–HCl,
pH 8.0, 500 mM NaCl, 10% glycerol, 0.02% Triton X-100,
40 mM imidazole and Complete protease inhibitor), and trans-
ferredtoa disposable gravity column.Thecolumnwas washed
with 30 ml of wash buffer and 90 ml of wash buffer without
protease inhibitor. Rad52 proteins were eluted by elution buf-
fer (20 mM Tris–HCl, pH 8.0, 500 mM NaCl, 10% glycerol,
0.02% Triton X-100 and 500 mM imidazole), and dialyzed
four times against 750 ml of buffer (20 mM Tris–HCl, pH 8.0,
500 mM NaCl, 10% glycerol and 0.02% Triton X-100).
Protein concentration was measured with Micro BCA Protein
Assay Reagent Kit (PIERCE).
Construction of a zebrafish RPA triple expression
construct
The open reading frame of RPA14 (GenBank BM860452) was
PCR ampliﬁed with primers (BamHI–RPA14F1: 50-cgGGAT-
CCatgacgggcgtttatgagtc-30 and EcoRI–RPA14R370: 50-gGA-
ATTCttgtttaaccactcattgacacttc-30), cut by BamHI and EcoRI,
and inserted into the BamHI and EcoRI sites of pGEX6P1
vectortogenerate‘RPA14pGEX6P1’.Theopenreading frame
of RPA32 (AI877547) was PCR ampliﬁed with primers (RBS-
RPA32F1: 50-TTGTTTAACTTTAAGAAGGAGATATACC-
atgtggaaccaaggtaaatacg-30 and XN-RPA32R833: 50-aaaaact-
cgagGCGGCCGCggctcttgtggatgttaggc-30). This PCR product
was used as template with primers (EagI-RBS: 50-CCC-
AAcggccgAATAATTTTGTTTAACTTTAAGAAGGAGAT-
ATACC-30 and XN-RPA32R833) to produce a product
that has EagI and NotI sites at the ends. This PCR product
was digested with EagI and inserted into the NotI site of
RPA14pGEX6P1 in the correct orientation to produce
‘RPA14 and 32pGEX6P1’. The open reading frame of RPA70
(AW133988) was PCR ampliﬁed with primers (EagI-R-
RPA70F1: 50-CCCAAcggccgAATAATTTTGTTTAACTT-
TAAGAAGGAGATATACCatgactgttagaccgtcggaag-30 and
XN-RPA70R1822: 50-aaaaactcgagGCGGCCGCgaccacggca-
gtccttctac-30), subcloned into pGEM-T Easy vector (Pro-
mega), digested with EcoRI and XhoI, and inserted into
the EcoRI and XhoI sites of the RPA14 and 32pGEX6P1
to generate ‘GST-RPA14, RPA32, RPA70 in pGEX6P1’.
Expression and purification of zebrafish RPA proteins
The RPA triple expression construct in BL21-CodonPlus
(DE3)-RIL cells was cultured in LB medium supplemented
with ampicillin and chloramphenicol at 37 Ct oA600 of 0.6,
and induced with 1 mM IPTG for 2 h. The bacterial pellet was
resuspended in 25 ml of P-BER reagent (PIERCE) and inclu-
sion bodies were puriﬁed according to the manufacturer’s
instructions. Inclusion bodies (150 mg) were resuspended
in 15 ml of solubilization buffer (50 mM CAPS, pH 11,
0.3% N-lauroylsarcosine, 5 mM DTT and 10 mMZ n C l 2),
and dialyzed twice for 2 h against buffer (20 mM Tris–
HCl, pH 8.5, 5 mM DTT and 10 mM ZnCl2), and once over-
night against the same buffer but at pH 7.5. NaCl was added to
150 mM and the sample was incubated with 1 ml bed volume
of glutathione beads (Amersham Biosciences) for 30 min
at 4 C. The beads were washed 5 times with 50 ml of buffer
(20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM, 10 mM
ZnCl2 and 0.02% Triton X-100). The beads were incubated
at 4 C overnight with 1 ml of PreScission protease
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NaCl, 5 mM DTT and 10 mM ZnCl2). The eluted RPA proteins
were collected and used for in vitro experiments.
Annealing assays
Annealing assays were done with two complementary
oligonucleotides (oligo-25: 50-GCAATTAAGCTCTAAGC-
CATCCGCAAAAATGACCTCTTATCAAAAGGA-30 and
oligo-26: 50-TCCTTTTGATAAGAGGTCATTTTTGCGGA-
TGGCTTAGAGCTTAATTGC-30). Oligo-26 was labeled
with [g-
32P]ATP (Amersham) using T4 polynucleotide kinase
(Roche). Speciﬁc conditions of annealing experiments are
given in the legend to Figure 4.
Targeting oligonucleotides
Sequences of the targeting oligonucleotides are shown in
Figure 5. Oligonucleotides were synthesized using cyanoethyl
phosphoramiditechemistry,andthen puriﬁedbyPAGE.These
targeting oligonucleotides have 50 phosphate modiﬁcations at
the 50 ends (Midland Certiﬁed Reagent Company, Inc.).
Microinjection of targeting oligonucleotides/Rad52
mixtures and DNA extraction from injected embryos
Injection needles were siliconized with AquaSil (Pierce)
reagent. One of the targeting oligonucleotides (10 fmol/nl
ﬁnal) and one of the Rad52 deletion proteins (80 or
660 fmol/nl ﬁnal) were preincubated for 20 min at room
temperature. One-cell stage embryos were microinjected
with 1–2 nl of the mixture, and cultured until shield to 80%
epiboly stages. To extract genomic DNA, individual embryos
were placed into 25 ml of ice-cold DNA extraction buffer
(10 mM Tris–HCl, pH 8.0, 2 mM EDTA, 0.2% Triton
X-100, 200 mg/ml Proteinase K) and incubated at 50 C for
16 h, then at 95 C for 10 min. To remove remaining targeting
oligonucleotide, 25 ml of Exonuclease I mixture [0.04 U/ml
Exonuclease I (New England Biolabs), 134 mM Glycine-
KOH, pH 9.5, 13.4 mM MgCl2, 20 mM 2-mercaptoethanol]
was added, and incubated at 37 C for 1 h and at 80 C for
20 min.
PCR-based mutation detection system
Mutant template was detected with a pair of PCR primers
(BrulATRFO: 50-AAGCTGAACAGTCAGAGTTGGTC-30
(Tm ¼ 55 C) and BrulMutMcAsR: 50-TGATTTCATAA-
ACTGCACCC-30 (Tm ¼ 48 C). BrulATRFO primer
matches a site at  250 bases upstream of the targeted site.
BrulMutMcAsR primer matches the mutant sequence, but has
a mismatch with the wild-type sequence at the 30 end. Each
20 ml reaction contained 200 mM of dNTP, 300 nM of each
primer, one-twentieth of the genomic DNA from a single
embryo and 0.7 U FastStart Taq DNA polymerase (Roche
Applied Science) in 1· PCR buffer with 2.0 mM MgCl2.
The thermal cycler (MJ Research, DNA Engine Tetrad,
PTC-225) was programmed as follows: 4 C for 1 min, 94 C
for 4.5 min (94 C for 15 s, 63 C for 30 s and 72 C for
30 s) · 38 cycles or more, 72 C for 7 min and 4 C until
collected. Note that the program was started at 4 C and that
the annealing temperature was signiﬁcantly higher than the
Tm of the primers. Tight contact between tubes and the heat
block was essential for suppressing false positives. We used
8-strip PCR tubes instead of 96-well plates.
RESULTS
With the aim to test the applicability of single-stranded
oligonucleotide-dependent gene targeting in zebraﬁsh
embryos, we ﬁrst carried out in vitro control experiments.
As gene targeting in bacteria is accelerated by b protein
which is believed to facilitate annealing of the introduced
single-stranded oligonucleotide to the cognate sequence in
the genome, we tested the zebraﬁsh homolog of b, Rad52,
for its annealing-promoting ability in vitro. RPA is known
to associate with single-stranded DNA in the replication
fork and prevent annealing. Our in vitro experiments therefore
tested whether Rad52 could displace zebraﬁsh RPA from the
DNA and facilitate annealing. Having found that this did
happen in vitro, we tested the ability of single-stranded
oligonucleotide co-injected with Rad52 to introduce a targeted
mutation into a gene within the zebraﬁsh genome in vivo.
Cloning of zebrafish Rad52
The coding region of Rad52 was PCR-ampliﬁed from a
cDNA library of 24 h stage zebraﬁsh embryos. We could
not amplify the Rad52 coding region with primers designed
from GeneScan prediction data (Sanger Center genome data-
base), but we were able to ﬁnd end sequences of zebraﬁsh
Rad52 in the genome database by using very short amino acid
sequences from chicken (19-CFGQY-23, numbering is based
on zebraﬁsh sequence) and medaka (427-MKKRRLDT*-434)
as BLAST queries. There is an in-frame stop codon (TAG)
upstream of the ATG initiation codon in the sequence we
derived (Figure 1), but we cannot exclude the possible exis-
tence of additional upstream exons. We found two splice
variants, a short isoform with an internal deletion within
the Rad51-binding domain, and a longer isoform that is
similar to Rad52 of other species (Figure 1). Zebraﬁsh
Rad52 showed high sequence homology to other species in
the N-terminal half that has DNA-binding and self-association
domains, as documented before (25,26). The sequence of the
C-terminal half is rather diverged except in the RPA-binding
region, a small stretch in the Rad51-binding domain, and a
nuclear localization signal. GenBank accession numbers for
longer and shorter isoforms are DQ021477 and DQ021478,
respectively.
Expression and purification of Rad52
Histidine-tagged full-length zebraﬁsh Rad52 was expressed as
a major band of the predicted size of 50.7 kDa and several
apparent proteolytic fragments (data not shown). Although
intact Rad52 could be isolated from this preparation, we rea-
soned that the region relevant for our purpose was probably
represented by the N-terminal DNA-binding domain, and
possibly by the RPA-binding domain (27). Therefore, several
Rad52 constructs truncated at the C-terminus were made, each
containing a nuclear localization signal (see Materials and
Methods). The deletion constructs ending in 327G, 342T,
355W, 362I and 376P showed multiple proteolytic frag-
ments, whereas 204Q, 205T, 206N, 317Q and 369S were
isolated mostly intact (Figure 2 and data not shown). Rad52
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analysis, although some tests were also done with full-length
Rad52.
Expression and purification of RPA proteins
We could not obtain soluble RPA proteins by expressing
them individually as GST-fusion proteins (data not shown).
Previous studies with yeast and human RPA showed that these
proteins could be expressed in soluble form when all three
subunits were expressed simultaneously (28,29). Therefore,
we generated a triple expression construct in which GST-
RPA14, RPA32 and RPA70 were expressed from a tricistronic
mRNA (Figure 3A). Using this construct, a fraction of
GST-RPA14 and RPA32 were expressed in soluble form,
but RPA70 was insoluble (Figure 3B). Therefore, we tried
to refold the RPA proteins. Inclusion bodies were puriﬁed
and solubilized in a high-pH buffer supplemented with N-
laurylsarcosine and DTT. After dialysis, most of the protein
remained soluble. It has been reported that RPA70, 32 and
14 form a tight heterotrimeric complex, which presumably
accounts for the fact that RPA32 and 70 were co-puriﬁed
with GST-RPA14 on glutathione beads (Figure 3B, right
panel). This heterotrimeric complex of zebraﬁsh RPA proteins
could bind strongly to poly(dT)50 and poly(dC)50, but weakly
to poly(dA)50 and poly(dG)50, as previously reported in other
species (29,30) (data not shown).
Rad52 facilitates annealing of oligonucleotides in
the presence of RPA
Annealing of the two complementary oligonucleotides studied
occurredslowlyat22 Cwhennoproteinwasadded(Figure4A
and B, control). This annealing was signiﬁcantly accelerated
by both truncated Rad52 proteins (Figure 4A and B), as
expected from the fact that these deletion proteins retain
the N-terminal DNA-binding domain. It has been reported
that incubation of both strands with yeast RPA inhibits anneal-
ing of complementary oligonucleotides, and that Rad52 can
displace RPA and mediate annealing if both proteins are from
the same species (31,32). Zebraﬁsh RPA likewise inhibited
annealing of oligonucleotides (Figure 4C, right). Addition of
Rad52 1–317Q NLS to RPA-bound oligonucleotides resulted
in annealing of the oligonucleotides (Figure 4C, middle), as
expected because this Rad52 derivative retains the RPA-
binding domain. Addition of Rad52 1–204Q NLS protein,
in which the RPA-binding domain was deleted, facilitated
annealing at a lower rate (Figure 4C, left).
We next asked whether truncated Rad52 proteins can accel-
erate annealing when onlyone of the complementary strands is
boundbyRPA.This mimics thesituationthatshouldhappen at
the replication fork in vivo in single-stranded oligonucleotide-
mediated mutagenesis. Without Rad52 proteins, annealing
occurred slowly (Figure 4D, left), and both Rad52 1–204Q
NLS and Rad52 1–317Q NLS proteins strongly accelerated
annealing under these conditions (Figure 4D, middle and
right). Similar results were obtained when full-lengthzebraﬁsh
Rad52 or b protein of bacteriophage l were used (data not
shown).
Microinjection of unmodified single-stranded
oligonucleotide and Rad52 1–317Q NLS can induce
a targeted mutation into the zebrafish genome
Having tested the reagents in vitro, we investigated whether
single-stranded oligonucleotides and Rad52 proteins can
be used for site-speciﬁc base substitution of the zebraﬁsh
genome. We chose the bruno-like gene (brul) as a target.
Figure 1. Multiple alignment of Rad52 from zebrafish and other species. Multiple alignments were made using the DNASIS software (Hitachi Software
Engineering). The longer splice isoform of zebrafish Rad52 is shown. Amino acid residues conserved in three or four species are highlighted in gray or black,
respectively. Known domains/regions are underlined. DNA-binding—regions that are involved in single-strand DNA binding. The amino acid sequence that is
deleted in the short isoform is indicated by an open gray box. Amino acids Q204 and Q317 are indicated by open gray ovals.
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to the vegetal pole of early embryos (33). The genomic
sequenceofthebrulgene wasobtainedfromtheSangerCenter
genome database, and the sequence around the targeted site
was veriﬁed by resequencing. The targeting oligonucleotides
are homologous to the exon sequence except for a single-
nucleotide substitution, which was chosen so that it will intro-
duce an in-frame stop codon into the brul ORF (Figure 5).
During the process of Okazaki fragment maturation in
mammals, the ﬁrst  30 nt are synthesized by DNA poly-
merase a that has no proof-reading activity (34), and are
subsequently displaced by DNA polymerase d from the
upstream direction (34,35). This is in contrast to the situation
in yeast where only 2–3 nt are displaced by DNA polymerase
d (36). As DNA replication in zebraﬁsh is likely to follow
the mammalian pattern, we designed targeting oligonucleo-
tides that have a longer distance between the mutation site
and the 50 end, in addition to targeting oligonucleotides that
have the mutation site at their center (Figure 5). As we do not
know the direction of DNA replication at the site, we designed
both sense and antisense oligonucleotides.
We developed a PCR-based mutation detection system in
which one of two PCR primers matches only the mutant
template, but is mismatched to the wild-type template at its
30 end (Figure 6A). Previously, this strategy has been ham-
pered by the emergence of false-positive bands caused by
Figure 2. Expression and purification of truncated zebrafish Rad52 proteins.
(A) SDS–PAGE analysisofbacterially expressedRad521–204QNLS protein.
Ppt. and Sup. are the pellet and supernatant derived from the initial lysate,
FT and Elution are the flow-through and eluted fractions of the column frac-
tionations. Rad52 1–204Q NLS showed the predicted molecular weight (MW)
of 26.6 kDa. (B) Rad52 1–317Q NLS protein. Lane designations as in (A).
The protein migrates as expected for its predicted MW of 39.4 kDa. Mark12;
molecular weight marker.
Figure 3. ExpressionandpurificationofRPAproteins.(A)Schematicdrawing
of tricistronic expression construct as described in Materials and Methods.
Ribosome binding sites inserted upstream of each open reading frame are
depicted as small open circles. Restriction enzyme sites that were used for
constructionareshown.(B)SDS–PAGEanalysisofRPAproteinsfrominduced
and uninduced cultures fractionated into precipitate (Ppt.) and supernatant
(Sup.). Most RPA proteins were found in the precipitate, with small fractions
of GST-RPA14 and RPA32 also found in the supernatant (asterisks). The final
preparation of RPA after refolding and GST removal is shown in the right
lane. Mark12; molecular weight marker.
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conditions for ampliﬁcation using a dilution series of mutant
plasmid DNA in the presence of a level of genomic DNA that
was higher than that encountered in the actual experiments.
The conditions chosen (see Materials and Methods) allow us
to detect one mutant copy in 1000 or 10000 wild-type copies
of the template using 38 or 42 cycles of ampliﬁcation,
respectively (Figure 6B); faint false positive bands appeared
Figure 4. Annealingassaysinvitro.(AandB)AnnealingofoligonucleotidesisacceleratedbytruncatedRad52proteins.Labeledoligo-26(125fmol)and100pmol
truncatedRad52proteinweremixedin50mlRPAbuffer(20mMTris–HCl,pH7.5,150mMNaCl,10%glycerol,1mMDTTand0.02%TritonX-100)andincubated
at 22 C for 20min. Then,125 fmolunlabeledoligo-25wasaddedto initiate annealing. At varioustimes,10ml wasremovedand 50 pmolofunlabeledoligo-26was
added to stop annealing. Samples were treated with 0.5% SDS and 0.1 mg/ml proteinase K for 15 min at 37 C, and analyzed by 10% PAGE. The type of truncated
Rad52thatwasusedisindicated;controlscontainedbufferinplaceofRad52.(C)Rad521–317QNLSmediatesannealingwhenbothstrandsarecomplexedbyRPA.
Labeled oligo-26 and unlabeled oligo-25 (188 fmol each) were preincubated separately with 260 pmol RPA in 75 ml RPA buffer for 20 min at 22 C, and then the
samplesweremixed.Aliquots(48ml)ofthismixturewereincubatedwith140pmolofeitherRad521–204QNLSorRad521–317QNLSproteins.Atvarioustimes,
the reactionwasstoppedandanalyzedbyPAGEasdescribedabove.(D) BothRad521–204QNLSandRad521–317QNLS mediateannealingwhenRPAis bound
to one strand. Unlabeled oligo-25 (375 fmol) was preincubated with 510 pmol RPA in 150 ml RPA buffer for 20 min at 22 C, while 125 fmol labeled oligo-26 was
preincubatedseparatelywith1.8nmolRad521–204QNLSorRad521–317QNLSin50mlRPAbuffer.Fiftymicrolitersoftheoligo-25+RPAsamplewasmixedwith
one of the oligo-26+Rad52 samples, incubated at 22 C and analyzed as described above.
Figure 5. Targeting oligonucleotides. The sense strand of the brul gene and the deduced amino acid sequence in the region of targeting are shown in the middle.
The targetingoligonucleotidesare homologousto thegenomic sequenceexceptfor a singlenucleotidesubstitution(indicated byopen boxes)that introduces a Stop
codon.pBrultargetSe,pBrultargetSe-10andpBrultargetSe-20oligonucleotidescorrespondtothesensestrand,whilepBrultargetAs,pBrultargetAs-10andpBrul
target Se-20 oligonucleotides correspond to the antisense strand (shown upside down). All of the targeting oligonucleotides carried a phosphate at the 50 end.
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recently developed LigAmp method (38). The method can be
used reliably for large numbers of samples as long as the
conditions are carefully controlled.
Exploratory in vivo targeting experiments were carried
out using the reagents and conditions generated through our
in vitro tests. In these experiments, we calibrated the assay by
diluting mutant plasmid DNA into genomic DNA extracted
from embryos at the same stage as the injected embryos,
and we applied the same level of total DNA (equivalent to
1/20th of one embryo) on each lane. Under these conditions,
the sensitivity of the assay was again  1 mutant copy in
1000 wild-type copies (Figure 6C, Controls). To test for tar-
geted recombination, the oligonucleotide/Rad52 mixture was
injected into one-cell stage embryos (see Materials and
Methods, and Figure 6 legend), and the embryos were allowed
to develop to the shield-to-80% epiboly stage. Injection of
Rad52 did not affect embryonic development, but the oligo-
nucleotides are toxic. The concentration used was chosen to
give a 50% survival by mid-gastrulation; embryos that
survived to this stage continued normal development for
several days, but we did not attempt to raise them to adult-
hood. Genomic DNA was extracted from individual-injected
embryos and tested in the PCR-based mutation detection
assay. We tested 80 embryos for each condition, i.e. for each
of the oligonucleotides shown in Figure 5 at two protein con-
centrations (see Materials and Methods). When using pBrul
target As-10 oligonucleotide and Rad52 1–317Q NLS protein
at a level of 660 fmol/nl, we found three apparent recombi-
nants among 80 embryos (Figure 6C). No recombinants were
detected using an 8-fold lower level of Rad52 1–317Q NLS
protein, or with any of the other oligonucleotides tested. In the
experiment in Figure 6C, the intensities of the bands suggest
that 2–3 mutant copies are present for 1000 wild-type copies in
sample62and 1per1000insamples64and66.Theseresults
were reproduced in an independent PCR experiment with the
same template DNAs.
DISCUSSION
Pioneering work in Escherichia coli (8) prompted us to
pursue the possibility that unmodiﬁed single-stranded
Figure 6. In vivo experiments. (A) A schematic of the PCR-based mutation
detection system. PCR primers are shown as black lines, template DNAs and
amplified fragments are shown as gray lines. A mutant plasmid was made by
PCR amplification of the targeted region of the brul gene with flanking
primers, followed by subcloning and in vitro site-directed mutagenesis.
(B) Sensitivity of the mutation detection system. Serial dilutions of the mutant
plasmid, as indicated, were mixed with a fixed amount of zebrafish genomic
DNA isolated from a group of embryos. Each 20 ml reaction contained 0.39 mg
genomicDNAthatcorrespondedto4.3 · 10
5copiesofthewild-typetemplate.
One mutant template in 1000 or 10000 wild-type templates can be detected
with 38 or 42 cycles, respectively. An aliquot (40%) of each reaction was
electrophoresed on 3% agarose gels, and stained with ethidium bromide.
(C) In vivo targeting experiments. Lanes labeled UC contain DNA from
individual-uninjected embryos (1/20th embryo equivalent per lane). Control
lanes contained DNA from uninjected embryos (1/20th embryo equivalent
per lane) with mutant plasmid DNA added in the proportion indicated. Lanes
labeled ‘Rad52 1–317Q NLS protein and pBrul target As-10’ contained DNA
from individual embryos (1/20th embryo equivalent per lane) injected with
these reagents. Amplification was carried out for 38 cycles. Injected embryos
number 62 (black box) and to a lesser extent 64 and 66 (gray boxes) tested
positive for the targeted mutation.
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mediating site-directed base substitution in the zebraﬁsh gen-
ome. In this paper, we report the biochemical basis for this
approach. It is known that when both strands of two com-
plementary oligonucleotides are bound by RPA, Rad52 can
displace the RPA and mediate annealing. For this activity,
species-speciﬁc interactions between RPA and Rad52 are
required (31,32). It was not known whether annealing of
oligonucleotides can be accelerated by Rad52 when only
one strand is bound by RPA, and whether species-speciﬁc
interactions of RPA and Rad52 are involved. These questions
are relevant to events that should happen at the replication
fork in unmodiﬁed single-stranded oligonucleotide-mediated
mutagenesis. Crystal structures of both Rad52 and RPA sug-
gest that the phosphate backbone of single-stranded DNA is
bound by both proteins while the bases remain exposed to the
solvent, making them accessible from the outside (25,26,39).
But it is still difﬁcult to predict the outcome of an annealing
event, because annealing of the oligonucleotides would
require gross conformational changes of both proteins if they
remain bound through the process. Our in vitro results showed
that annealing of oligonucleotides was accelerated by trun-
cated Rad52 and by b protein when only one strand was
bound by RPA, and that species-speciﬁc interactions between
RPA and Rad52 do not appear to be necessary. This suggests
that truncated Rad52 proteins that retain only the annealing
domain and even b protein of bacteriophage l might be uti-
lized in unmodiﬁed single-stranded oligonucleotide-mediated
mutagenesis in animal cells.
In our exploratory in vivo experiments, we found a low
frequency of recombinants when we microinjected pBrul tar-
get As-10 oligonucleotide with Rad52 1-317Q NLS protein. It
is reasonable that we found recombinants by using an oligonu-
cleotide whose 50 homology region is longer than 30, but
which still carries a sufﬁcient region of homology 30 of the
targeted site. Further, the highest concentration of protein that
was tested appeared to be the most effective. We found appar-
ent recombinants in 3 of the 80 embryos tested with this par-
ticular combination of protein concentration and targeting
oligonucleotide. The intensity of the PCR product suggests
that only a small number of targeted copies existed in the
genomes of these embryos, presumably because recombina-
tion took place in one of several hundred cells at the blastula
stage. But optimal design principles of targeting oligonu-
cleotides and the optimal domain architecture of Rad52 pro-
teins remain to be determined in future studies. Various ways
of delivery, such as expression of annealing enzymes from
transgenes, may also be tested. We believe that, if this method
is to be practical for mutagenesis, the overall frequency needs
to be increased greatly.
Finally, we developed a simple and sensitive PCR-based
mutation detection system. As this system does not require
any special equipment or reagents other than commercially
available hot start polymerases, it can be used as a cost-
effective point mutation detection system.
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